Erisyon Information
Contact top employees from
Erisyon
Summary
Erisyon is a private company. The company currently specializes in the Biotechnology area. The Erisyon annual revenue is estimated at < 1M. To connect with Erisyon employee register on SignalHire.
Organization Website | erisyon.com |
Industries | |
Headquarters Location | 360 Nueces St, Austin, Texas, US |
Employees Size | 1-10 employees |
Specialties | single molecule protein sequencing, diagnostics, oncology, plant sciences, drug development, industrial biology |
Founded | 2018 |
Operating Status | Independent Company |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Erisyon shows a diverse range of experience levels:
10% have been with the company for less than 1 year30% for 1–2 years20% for 3–4 years30% for 5–7 years10% for 8–10 yearsEx-employees positions
In Company
In New Company
Contact top employees from
Erisyon
Angela Bardo
Co-Founder and Vice President of Product Development
Talli Somekh
Co-Founder and CEO
Heather Stout
Consultant
Evan Jones
Software Engineer
Thomas Blom
Director of Software Engineering
James Mapes
Lead Researcher of the Technology Access Facility
Mariah Austin
Scientist
Jagannath Swaminathan
Co-Founder and Chief Technology Officer
Similar Companies
FAQ
Erisyon operates in the Biotech industries. More details can be found on the official website: erisyon.com.
The headquarters of Erisyon are located in Austin, United States.
Erisyon currently employs 1-10 people.
Erisyon's revenue is approximately < 1M.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
